Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Non-cash Items: 2023-2025

Historic Non-cash Items for InMed Pharmaceuticals (INM) over the last 2 years, with Sep 2025 value amounting to $50,055.

  • InMed Pharmaceuticals' Non-cash Items fell 36.39% to $50,055 in Q3 2025 from the same period last year, while for Sep 2025 it was $50,055, marking a year-over-year decrease of 36.39%. This contributed to the annual value of $72,549 for FY2025, which is 60.69% down from last year.
  • InMed Pharmaceuticals' Non-cash Items amounted to $50,055 in Q3 2025, which was down 31.01% from $72,549 recorded in Q2 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Non-cash Items peaked at $1.3 million during Q4 2023, and registered a low of $50,055 during Q3 2025.
  • In the last 3 years, InMed Pharmaceuticals' Non-cash Items had a median value of $99,006 in 2025 and averaged $335,770.
  • Per our database at Business Quant, InMed Pharmaceuticals' Non-cash Items spiked by 53.07% in 2024 and then plummeted by 90.97% in 2025.
  • Quarterly analysis of 3 years shows InMed Pharmaceuticals' Non-cash Items stood at $1.3 million in 2023, then tumbled by 89.07% to $136,899 in 2024, then crashed by 36.39% to $50,055 in 2025.
  • Its Non-cash Items was $50,055 in Q3 2025, compared to $72,549 in Q2 2025 and $99,006 in Q1 2025.